The 11 analysts offering 12-month price forecasts for Esperion Therapeutics Inc have a median target of 8.00, with a high estimate of 30.00 and a low estimate of 4.00. The median estimate represents a +111.64% increase from the last price of 3.78.
The current consensus among 11 polled investment analysts is to Buy stock in Esperion Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$2.28
Reporting Date Feb 22
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.